Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

The only revenue IPCI has on the slate for calendar year 2018 is approximately $5M from FocalinXR sales by PAR.

So unless Dr. Odidi's suddenly decided to change everything that he's been doing over the past 4 years running now and find a way to secure partnership deals on their Oxy NDA candidate, Regabatin or PODRAS...I don't see any way another offering is gonna be avoided...and another offering arriving here soon is gonna guarantee a reverse split.

Dreaming about some last second Glucophage licensing deal being secured in China to me is just wishful thinking at this already late stage!

We've had to figure out for ourselves that everything Dr. Odidi's been doing in China so far has only been for himself. So I very much doubt that he's gonna pull some last second miracle touchdown out of his bag of tricks and land some Chinese licensing deal on Gluco...but I will gladly eat my words if I'm wrong cheers